Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

White coat hypertension: relevance to clinical and emergency medical services personnel.

Khan TV, Khan SS, Akhondi A, Khan TW.

MedGenMed. 2007 Mar 13;9(1):52. Review.

2.

Ambulatory blood pressure monitoring and clinical characteristics of the true and white-coat resistant hypertension.

Veglio F, Rabbia F, Riva P, Martini G, Genova GC, Milan A, Paglieri C, Carra R, Chiandussi L.

Clin Exp Hypertens. 2001 Apr;23(3):203-11.

PMID:
11339687
3.

Cognitive and autonomic dysfunction measures in normal controls, white coat and borderline hypertension.

Shehab A, Abdulle A.

BMC Cardiovasc Disord. 2011 Jan 11;11:3. doi: 10.1186/1471-2261-11-3.

4.

What a high prevalence of white coat hypertension in society!

Helvaci MR, Seyhanli M.

Intern Med. 2006;45(10):671-4. Epub 2006 Jun 15.

5.

Predictors for the white coat effect in general practice patients with suspected and treated hypertension.

Lindbaek M, Sandvik E, Liodden K, Mjell J, Ravnsborg-Gjertsen K.

Br J Gen Pract. 2003 Oct;53(495):790-3.

6.

Prognosis of "masked" hypertension and "white-coat" hypertension detected by 24-h ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study.

Ohkubo T, Kikuya M, Metoki H, Asayama K, Obara T, Hashimoto J, Totsune K, Hoshi H, Satoh H, Imai Y.

J Am Coll Cardiol. 2005 Aug 2;46(3):508-15.

7.

White coat effect in treated hypertensive patients: sex differences.

Myers MG, Reeves RA.

J Hum Hypertens. 1995 Sep;9(9):729-33.

PMID:
8551486
8.
9.

White-coat hypertension: a clinical review.

Celis H, Fagard RH.

Eur J Intern Med. 2004 Oct;15(6):348-357.

PMID:
15522568
10.

Clinical implications of white coat hypertension.

Carek PJ, Carson DS, Cooke CE, Weart CW.

Am Fam Physician. 1995 Jul;52(1):163-8. Review.

PMID:
7604760
11.
12.
13.

Long-term risk of sustained hypertension in white-coat or masked hypertension.

Mancia G, Bombelli M, Facchetti R, Madotto F, Quarti-Trevano F, Polo Friz H, Grassi G, Sega R.

Hypertension. 2009 Aug;54(2):226-32. doi: 10.1161/HYPERTENSIONAHA.109.129882. Epub 2009 Jun 29.

14.

Clinical implications of white coat hypertension: an ambulatory blood pressure monitoring study.

Manning G, Rushton L, Millar-Craig MW.

J Hum Hypertens. 1999 Dec;13(12):817-22.

PMID:
10618670
15.

[Influence of blood pressure variability during office visit on the estimation of blood pressure control in treated hypertensive patients].

Villeneuve F, Rosenbaum D, Gury C, Girerd X.

Ann Cardiol Angeiol (Paris). 2012 Jun;61(3):198-202. doi: 10.1016/j.ancard.2012.04.022. Epub 2012 May 23. French.

PMID:
22677179
16.

White-coat hypertension.

Martin CA, McGrath BP.

Clin Exp Pharmacol Physiol. 2014 Jan;41(1):22-9. doi: 10.1111/1440-1681.12114. Review.

PMID:
23682974
17.

Determinants of the white-coat effect in hypertensive subjects.

Mansoor GA, McCabe EJ, White WB.

J Hum Hypertens. 1996 Feb;10(2):87-92.

PMID:
8867561
18.

Do we need out-of-office blood pressure in every patient?

Parati G, Valentini M.

Curr Opin Cardiol. 2007 Jul;22(4):321-8. Review.

PMID:
17556885
19.

Prognostic significance of ambulatory blood pressure.

Imai Y.

Blood Press Monit. 1999 Oct;4(5):249-56. Review.

PMID:
10547646
20.

Long-Term Stroke Risk Due to Partial White-Coat or Masked Hypertension Based on Home and Ambulatory Blood Pressure Measurements: The Ohasama Study.

Satoh M, Asayama K, Kikuya M, Inoue R, Metoki H, Hosaka M, Tsubota-Utsugi M, Obara T, Ishiguro A, Murakami K, Matsuda A, Yasui D, Murakami T, Mano N, Imai Y, Ohkubo T.

Hypertension. 2016 Jan;67(1):48-55. doi: 10.1161/HYPERTENSIONAHA.115.06461. Epub 2015 Nov 2.

Supplemental Content

Support Center